Xpert® SARS-CoV-2 Control Panel M430
COVID-19 continues to impact respiratory disease surveillance and patient care, requiring accurate and consistent molecular testing. The Xpert® SARS-CoV-2 Control Panel M430 supports performance monitoring of Xpert® Xpress SARS-CoV-2 assays on the Cepheid GeneXpert® system, helping laboratories verify assay performance and maintain confidence in respiratory testing workflows.
Xpert® SARS-CoV-2/Flu/RSV Control Panel M509
With broad respiratory assay coverage, the Xpert® SARS-CoV-2/Flu/RSV Control Panel M509 supports molecular testing across key Cepheid GeneXpert® respiratory assays, including Xpert® Xpress Flu, Flu/RSV, CoV-2 plus, and CoV-2/Flu/RSV plus assays, helping laboratories streamline quality monitoring across multiple respiratory testing workflows.
Xpert® Carba-R QC Panel M219
Carbapenem-resistant Gram-negative bacteria are a growing global public health concern, limiting treatment options and driving the need for rapid detection of resistance mechanisms. Designed for use with the Xpert® Carba-R Assay, the Xpert® Carba-R QC Panel M219 supports performance monitoring on the Cepheid GeneXpert® system by evaluating the five major carbapenemase targets: KPC, NDM, VIM, OXA-48-like, and IMP-1.
Explore TB Controls
Browse MMQCI’s tuberculosis control portfolio designed to support accurate performance monitoring on the Cepheid GeneXpert® system. Our INTROL® TB Panels help laboratories assess detection of Mycobacterium tuberculosis as well as drug resistance targets across the Xpert MTB/RIF and MTB/XDR assays.
Explore Oncology Controls
Looking for controls beyond infectious disease testing? Browse MMQCI's growing portfolio of oncology reference materials, built for assay verification & routine quality monitoring, and designed to support molecular testing for bladder cancer and key leukemia markers, including BCR-ABL, PML-RARA, and NPM1.
Factor II & Factor V Thrombosis Controls
MMQCI offers Factor II and Factor V thrombosis controls designed to support performance monitoring and verification of molecular testing workflows. Developed for use with the Cepheid GeneXpert® system, these controls help laboratories assess detection of key hereditary thrombophilia markers. Available products include: